1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow ACI-7104.056 at Dose A: new trials by email Literature Review of ACI-7104.056 at Dose A trials Research Report on ACI-7104.056 at Dose A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease Placebo, ACI-7104.056 at Dose A, ACI-7104.056 at Dose B (optional) - Parkinson Disease, Parkinson Disease 6, Early-Onset | Phase 2 | Active not recruiting | AC Immune SA | 150 | 2023-07-24 | 2026-10-01 |
Parkinson Disease (1) · Parkinson Disease 6, Autosomal Recessive Early-Onset (1)
AC Immune SA (1)
Germany (1) · Spain (1) · United Kingdom (1)